S
Sanjeev Saksena
Researcher at Atlantic Health System
Publications - 174
Citations - 6606
Sanjeev Saksena is an academic researcher from Atlantic Health System. The author has contributed to research in topics: Atrial fibrillation & Cardioversion. The author has an hindex of 44, co-authored 169 publications receiving 6463 citations. Previous affiliations of Sanjeev Saksena include University of Minnesota & Newark Beth Israel Medical Center.
Papers
More filters
Journal ArticleDOI
ACC/AHA Guidelines for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation)
Gabriel Gregoratos,Melvin D. Cheitlin,A. Conill,Andrew E. Epstein,Christopher L. Fellows,T. B. Ferguson,Roger A. Freedman,Mark A. Hlatky,Gerald V. Naccarelli,Sanjeev Saksena,Robert C. Schlant,Michael J. Silka +11 more
TL;DR: These guidelines include expanded sections on selection of pacemakers and ICDs, optimization of technology, cost, and follow-up of implanted devices, and recommendations that are evidence based whenever possible.
Journal ArticleDOI
Prevention of implantable-defibrillator shocks by treatment with sotalol. d,l-Sotalol Implantable Cardioverter-Defibrillator Study Group.
Antonio Pacifico,Stefan H. Hohnloser,John H. Williams,Ben Tao,Sanjeev Saksena,Philip D. Henry,Eric N. Prystowsky +6 more
TL;DR: Oral sotalol was safe and efficacious in reducing the risk of death or the delivery of a first defibrillator shock whether or not ventricular function was depressed.
Journal ArticleDOI
Prevention of recurrent atrial fibrillation with chronic dual-site right atrial pacing
Sanjeev Saksena,Atul Prakash,Michael R. S. Hill,Ryszard B. Krol,Anand N. Munsif,Philip P. Mathew,Rahul Mehra +6 more
TL;DR: It is concluded that multisite right atrial pacing is feasible, effective and safe for long-term application and should be considered either as the primary mode or in patients unresponsive to single-site pacing.
Journal ArticleDOI
A classification of atrial flutter and regular atrial tachycardia according to electrophysiological mechanisms and anatomical bases; a Statement from a Joint Expert Group from The Working Group of Arrhythmias of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology.
N. Saoudi,Francisco G. Cosio,Albert L. Waldo,S. A. Chen,Y. Iesaka,Michael D. Lesh,Sanjeev Saksena,J. Salerno,W. Schoels +8 more
Journal ArticleDOI
Long-term outcome of patients with drug-refractory atrial flutter and fibrillation after single- and dual-site right atrial pacing for arrhythmia prevention
TL;DR: Dual-site right atrial pacing is safe, achieves long-term rhythm control in most patients, decreases the need for cardioversion, and antithrombotic therapy can be selectively reduced.